What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Biochemistry
Kazuhiko Yanai spends much of his time researching Pathology, Histamine, Histamine H1 receptor, Internal medicine and Endocrinology.
His research on Pathology frequently connects to adjacent areas such as Positron emission tomography.
His research in Histamine is mostly focused on Histaminergic.
The concepts of his Histaminergic study are interwoven with issues in Orexin, Histamine H3 receptor, Histamine receptor, Neuroscience and Convulsion.
His Histamine H1 receptor research includes elements of Doxepin, Anesthesia, Pharmacology, Antihistamine and Human brain.
When carried out as part of a general Internal medicine research project, his work on Neuropeptide, Hypothalamus, Neurotransmitter and Dopamine receptor D3 is frequently linked to work in Leptin, therefore connecting diverse disciplines of study.
His most cited work include:
- Psychosis pathways converge via D2high dopamine receptors. (280 citations)
- Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors (263 citations)
- 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease (254 citations)
What are the main themes of his work throughout his whole career to date?
Kazuhiko Yanai focuses on Histamine, Internal medicine, Pharmacology, Histamine H1 receptor and Endocrinology.
His Histamine research integrates issues from Receptor, Histidine decarboxylase, Histamine H3 receptor and Histamine H2 receptor.
His Pharmacology study focuses on Antihistamine in particular.
He has researched Histamine H1 receptor in several fields, including Histamine receptor, Doxepin, Human brain and Positron emission tomography.
His Positron emission tomography research is multidisciplinary, relying on both Alzheimer's disease, Dementia and Nuclear magnetic resonance.
Kazuhiko Yanai studies Endocrinology, namely Hippocampus.
He most often published in these fields:
- Histamine (23.23%)
- Internal medicine (21.51%)
- Pharmacology (21.04%)
What were the highlights of his more recent work (between 2014-2021)?
- Pathology (13.03%)
- Histamine (23.23%)
- Internal medicine (21.51%)
In recent papers he was focusing on the following fields of study:
Kazuhiko Yanai mainly focuses on Pathology, Histamine, Internal medicine, Positron emission tomography and Pharmacology.
Specifically, his work in Histamine is concerned with the study of Histaminergic.
His biological study spans a wide range of topics, including Fluorodeoxyglucose and Endocrinology.
His work deals with themes such as Heparan sulfate and Histamine H3 receptor, which intersect with Endocrinology.
Kazuhiko Yanai interconnects Alzheimer's disease, Magnetic resonance imaging and Amyloid in the investigation of issues within Positron emission tomography.
As a part of the same scientific family, he mostly works in the field of Pharmacology, focusing on Histamine H1 receptor and, on occasion, Histamine receptor, Antihistamine, Doxepin, Sedative and Cell biology.
Between 2014 and 2021, his most popular works were:
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. (191 citations)
- Propagation of pathological α-synuclein in marmoset brain. (91 citations)
- [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease (86 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Biochemistry
His primary scientific interests are in Pathology, Alzheimer's disease, Positron emission tomography, Dementia and Nuclear medicine.
His study in the fields of Amyloid under the domain of Pathology overlaps with other disciplines such as Germline mutation.
His work on Tau protein as part of general Alzheimer's disease study is frequently linked to Biological property, bridging the gap between disciplines.
His study in Positron emission tomography is interdisciplinary in nature, drawing from both Frontal lobe, Neuroimaging and Enantiomer.
Dementia is a subfield of Internal medicine that he explores.
His research investigates the connection between Structure–activity relationship and topics such as Pharmacology that intersect with issues in Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
